508225 | InSolution™ Tamoxifen, 4-Hydroxy-, (Z)- - CAS 68047-06-3 - Calbiochem

508225
Price could not be retrieved
Minimum Quantity needs to be mulitiple of
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      View Pricing & Availability
      Click To Print This Page

      Overview

      Replacement Information

      Key Specifications Table

      Empirical FormulaCAS #
      C₂₆H₂₉NO₂ 68047-06-3

      Pricing & Availability

      Catalog NumberAvailability Packaging Qty/Pack Price Quantity
      5.08225.0001
      Retrieving availability...
      Limited AvailabilityLimited Availability
      Stocked 
      Discontinued
      Limited Quantities Available
      Available
        Remaining : Will advise
          Remaining : Will advise
          Will advise
          Contact Customer Service

          Glass bottle 2 mg
          Retrieving price...
          Price could not be retrieved
          Minimum Quantity needs to be mulitiple of
          Upon Order Completion More Information
          You Saved ()
           
          Request Pricing
          Description
          Catalogue Number508225
          Brand Family Calbiochem®
          Synonyms(Z)-4-(1-(4-(Dimethylaminoethoxy)phenyl)-2-phenyl-1-butenyl)phenol, (Z)-4-(1-(4-(2-(Dimethylamino)ethoxy)phenyl)-2-phenylbut-1-enyl)phenol, (Z)-4-Hydroxytamoxifen, (Z)-4-OH-TAM, trans-4-Hydroxytamoxifen
          References
          ReferencesGundimeda, U., et al. 1996. J. Biol. Chem. 271, 13504.
          Ye, Q. and Bodell, W.J. 1996. Carcinogenesis 17, 1747.
          Laser, R., et al. 1985. Eur. J. Cancer Clin. Oncol. 21, 985.
          Jordan, V.C., et al. 1978. J. Toxicol. Environ. Health 4, 364.
          Product Information
          CAS number68047-06-3
          FormLiquid
          FormulationA 10 mM (2 mg/516 µL) sterile-filtered solution of (Z)-4-Hydroxytamoxifen (Cat. No. 579002) in EtOH.
          Hill FormulaC₂₆H₂₉NO₂
          Chemical formulaC₂₆H₂₉NO₂
          Hygroscopic Hygroscopic
          ReversibleY
          Structure formula ImageStructure formula Image
          Applications
          Biological Information
          Primary TargetEstrogen receptor
          Purity≥99% by HPLC
          Physicochemical Information
          Cell permeableY
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          R PhraseR: 11

          Highly flammable.
          S PhraseS: 16-7

          Keep away from sources of ignition - No Smoking.
          Keep container tightly closed.
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Dry Ice Only
          Toxicity Harmful & Carcinogenic / Teratogenic
          Hazardous Materials Attention: Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
          Storage ≤ -70°C
          Protect from Light Protect from light
          Hygroscopic Hygroscopic
          Avoid freeze/thaw Avoid freeze/thaw
          Do not freeze Ok to freeze
          Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C). Aliquots are stable for up to 6 months at -20°C. Use only anhydrous, 200 proof ethanol for further dilutions.
          Packaging Information
          Packaged under inert gas Packaged under inert gas
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          SDS

          Title

          Safety Data Sheet (SDS) 

          References

          Reference overview
          Gundimeda, U., et al. 1996. J. Biol. Chem. 271, 13504.
          Ye, Q. and Bodell, W.J. 1996. Carcinogenesis 17, 1747.
          Laser, R., et al. 1985. Eur. J. Cancer Clin. Oncol. 21, 985.
          Jordan, V.C., et al. 1978. J. Toxicol. Environ. Health 4, 364.
          Data Sheet

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision17-January-2014 JSW
          Synonyms(Z)-4-(1-(4-(Dimethylaminoethoxy)phenyl)-2-phenyl-1-butenyl)phenol, (Z)-4-(1-(4-(2-(Dimethylamino)ethoxy)phenyl)-2-phenylbut-1-enyl)phenol, (Z)-4-Hydroxytamoxifen, (Z)-4-OH-TAM, trans-4-Hydroxytamoxifen
          DescriptionA cell-permeable, active metabolite of Tamoxifen (Cat. No. 579000) that acts as a potent inhibitor of PKC. It is more potent than the parent compound and inhibits PKC by modifying its catalytic domain.
          FormLiquid
          FormulationA 10 mM (2 mg/516 µL) sterile-filtered solution of (Z)-4-Hydroxytamoxifen (Cat. No. 579002) in EtOH.
          Intert gas (Yes/No) Packaged under inert gas
          CAS number68047-06-3
          Chemical formulaC₂₆H₂₉NO₂
          Structure formulaStructure formula
          Purity≥99% by HPLC
          Storage ≤ -70°C
          Hygroscopic
          Protect from light
          Avoid freeze/thaw
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C). Aliquots are stable for up to 6 months at -20°C. Use only anhydrous, 200 proof ethanol for further dilutions.
          Toxicity Harmful & Carcinogenic / Teratogenic
          ReferencesGundimeda, U., et al. 1996. J. Biol. Chem. 271, 13504.
          Ye, Q. and Bodell, W.J. 1996. Carcinogenesis 17, 1747.
          Laser, R., et al. 1985. Eur. J. Cancer Clin. Oncol. 21, 985.
          Jordan, V.C., et al. 1978. J. Toxicol. Environ. Health 4, 364.